Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 May 24;292(6532):1355–1357. doi: 10.1136/bmj.292.6532.1355

Oral contraceptives and hepatocellular carcinoma.

J Neuberger, D Forman, R Doll, R Williams
PMCID: PMC1340366  PMID: 3011185

Abstract

A series of 26 white women aged under 50 who developed hepatocellular carcinoma in a non-cirrhotic liver were studied for the possible role of oral contraceptives. Eighteen of the women had used the "pill" for a median of eight years. Over 1300 women whose use of the pill had been determined in another study served as controls. Patients and controls were divided into five age and four calendar groups and the relative risks associated with oral contraceptives calculated by multivariate analysis. Short term use of the pill was not associated with an increased risk of tumour development; nevertheless, use for eight years or more was associated with a 4.4-fold increased risk (p less than 0.01). When patients with markers of hepatitis B virus infection were excluded the relative risk was 7.2 (p less than 0.01). In both instances the absolute risk for developing hepatoma remained low.

Full text

PDF
1355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlercreutz H., Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med. 1970 Nov;49:630–648. doi: 10.1016/s0002-9343(70)80130-9. [DOI] [PubMed] [Google Scholar]
  2. Bréchot C., Nalpas B., Couroucé A. M., Duhamel G., Callard P., Carnot F., Tiollais P., Berthelot P. Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med. 1982 Jun 10;306(23):1384–1387. doi: 10.1056/NEJM198206103062302. [DOI] [PubMed] [Google Scholar]
  3. Edmondson H. A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976 Feb 26;294(9):470–472. doi: 10.1056/NEJM197602262940904. [DOI] [PubMed] [Google Scholar]
  4. Forman D., Doll R., Peto R. Trends in mortality from carcinoma of the liver and the use of oral contraceptives. Br J Cancer. 1983 Sep;48(3):349–354. doi: 10.1038/bjc.1983.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henderson B. E., Preston-Martin S., Edmondson H. A., Peters R. L., Pike M. C. Hepatocellular carcinoma and oral contraceptives. Br J Cancer. 1983 Sep;48(3):437–440. doi: 10.1038/bjc.1983.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. 1977 Aug;73(2):386–394. [PubMed] [Google Scholar]
  7. MacCornack F. A., Nathan J. K., Covey L. S., Wynder E. L. Oral contraceptive use. Epidemiology. N Y State J Med. 1977 Feb;77(2):200–202. [PubMed] [Google Scholar]
  8. Mays E. T., Christopherson W. Hepatic tumors induced by sex steroids. Semin Liver Dis. 1984 May;4(2):147–157. doi: 10.1055/s-2008-1040654. [DOI] [PubMed] [Google Scholar]
  9. McPherson K., Neil A., Vessey M. P., Doll R. Oral contraceptives and breast cancer. Lancet. 1983 Dec 17;2(8364):1414–1415. doi: 10.1016/s0140-6736(83)90936-4. [DOI] [PubMed] [Google Scholar]
  10. Mettlin C., Natarajan N. Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors. J Surg Oncol. 1981;18(1):73–85. doi: 10.1002/jso.2930180112. [DOI] [PubMed] [Google Scholar]
  11. Neuberger J., Portmann B., Nunnerley H. B., Laws J. W., Davis M., Williams R. Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet. 1980 Feb 9;1(8163):273–276. doi: 10.1016/s0140-6736(80)90776-x. [DOI] [PubMed] [Google Scholar]
  12. Tesluk H., Lawrie J. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med. 1981 Jun;105(6):296–299. [PubMed] [Google Scholar]
  13. Vana J., Murphy G. P., Aronoff B. L., Baker H. W. Primary liver tumors and oral contraceptives. Results of a survey. JAMA. 1977 Nov 14;238(20):2154–2158. [PubMed] [Google Scholar]
  14. Vessey M., Baron J., Doll R., McPherson K., Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983 Apr;47(4):455–462. doi: 10.1038/bjc.1983.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wanless I. R., Medline A. Role of estrogens as promoters of hepatic neoplasia. Lab Invest. 1982 Mar;46(3):313–320. [PubMed] [Google Scholar]
  16. Yager J. D., Jr, Yager R. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res. 1980 Oct;40(10):3680–3685. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES